Single Patient Investigational Treatment for Cree Leukoencephalopathy
NCT07300397
·
clinicaltrials.gov ↗
NA
Phase
ACTIVE_NOT_RECRUITING
Status
1
Enrollment
OTHER
Sponsor class
Conditions
Cree Leukoencephalopathy
Interventions
DRUG:
Fosigotifator
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre